102 related articles for article (PubMed ID: 17510245)
1. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling.
Kilić A; Bubikat A; Gassner B; Baba HA; Kuhn M
Endocrinology; 2007 Sep; 148(9):4162-9. PubMed ID: 17510245
[TBL] [Abstract][Full Text] [Related]
2. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
[TBL] [Abstract][Full Text] [Related]
4. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
[TBL] [Abstract][Full Text] [Related]
5. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
7. Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice.
Kirchhof P; Fabritz L; Kilić A; Begrow F; Breithardt G; Kuhn M
J Mol Cell Cardiol; 2004 May; 36(5):691-700. PubMed ID: 15135664
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
9. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
10. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
11. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB.
Gopi V; Subramanian V; Manivasagam S; Vellaichamy E
Mol Cell Biochem; 2015 Nov; 409(1-2):67-79. PubMed ID: 26215453
[TBL] [Abstract][Full Text] [Related]
14. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy.
Frank D; Kuhn C; van Eickels M; Gehring D; Hanselmann C; Lippl S; Will R; Katus HA; Frey N
Circulation; 2007 Nov; 116(22):2587-96. PubMed ID: 18025526
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
16. Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Li Y; Saito Y; Kuwahara K; Rong X; Kishimoto I; Harada M; Adachi Y; Nakanishi M; Kinoshita H; Horiuchi M; Murray M; Nakao K
Endocrinology; 2009 Aug; 150(8):3759-65. PubMed ID: 19372206
[TBL] [Abstract][Full Text] [Related]
17. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Hamanaka I; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Endocrinology; 2004 Feb; 145(2):951-8. PubMed ID: 14592959
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
19. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.
Yoshihara F; Tokudome T; Kishimoto I; Otani K; Kuwabara A; Horio T; Kawano Y; Kangawa K
Clin Exp Nephrol; 2015 Apr; 19(2):197-207. PubMed ID: 24845230
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
